John Perentesis
Executive Co-Director, Cancer & Blood Diseases Institute at Cincinnati Children\'s Hospital Medical Center
- Role
- Executive Co-director, Cancer Institute at Cincinnati Children's
- Location
- Cincinnati, OH, US
- LinkedIn followers
- 500 followers
About John Perentesis
Our mission is to use disruptive innovation to cure cancer in children and young adults, and assure survivors longevity with wellness. We\'re proud to be ranked as the #1 children\'s cancer program in the nation by US News.Our strategic plan targets:(1) Next generation precision medicine and new drug design/discovery/development,(2) New immune and cellular engineering therapies, and (3) Advanced radiation/proton therapies. Our work led to the recent FDA pediatric approvals for Selumetinib and Vyxeos/CPX-351, and we performed the first in human clinical trial of ultrahigh dose rate FLASH proton therapy for cancer.I\'m Co-Director of the Cancer & Blood Disease Institute, and the Chief of Oncology and Proton Therapy Programs at Cincinnati Children\'s Hospital. We are a 102-bed dedicated pediatric/young adult cancer center within a 650 bed academic children\'s hospital spanning two campuses. Cincinnati Children’s is an international referral center for relapse and high-risk cancer care and stem cell transplant. The Cincinnati Children’s Cancer/Blood Institute has ~ employees and over 100 MD, PhD and MD/PhD board-certified and research faculty organized in “team science” clinical/translational specialty programs in leukemias/lymphomas and marrow failure, brain tumors, neuroblastoma, musculoskeletal and NF/neural tumors, liver tumors, renal tumors, testicular/ovarian tumors, novel radiation therapy approaches, vascular tumors, and cancer survivorship. The Cincinnati Children’s Cancer/Blood Institute incorporates the largest portfolio of pediatric & young adult-focused programs in new anticancer drug discovery through programs in genomics integrated with in-silico drug design and high throughput screening. The clinical translational efforts include the nation’s largest integrated pediatric & young adult new drug testing-phase I and stem cell transplant program. The program has pioneered research in genomic-driven therapies and cellular engineering & therapeutics. A specialized cancer clinical trials center supports extensive efforts in investigator-initiated IND clinical trials, PIP, and network/consortium studies. I have leadership roles in national pediatric oncology, and direct our efforts in planning, construction and operations of our proton treatment & research center, CCHMC/Oncology Advanced Therapies Network (ACTN), and next-generation patient & family care navigation in collaboration with the University of Cincinnati School of Design, Architecture, Art and Planning/DAAP.
Experience
Executive Co-director, Cancer Institute
Sep 2012 — Present · Cincinnati, OH, US
Education
University of Michigan Medical School
Doctor of Medicine (MD), Medicine
1976 — 1980
Skills
- Molecular Biology
- Drug Discovery
- Research
- Cell
- Cell Culture
- Science
- Hospitals
- Treatment
- Medical Research
- Medical Education
- Translational Research
- Drug Development
- Cancer
- Oncology
- Cancer Centers
- Life Sciences
- Biochemistry
- Biotechnology
- Public Health
- Genetics
- Genomics
- Healthcare
- Biomarkers
- Healthcare Management
- Medicine
- Hematology
- Epidemiology
- Clinical Research
- Clinical Trials
- Pharmacogenomics
- Pediatrics
- Cell Biology
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.